Ayr Wellness (AYR.A) AI Stock Analysis

• Market Cap: $18.10M
• Dividend Yield: N/A
• Average Volume (3M): 62.64K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.99
• Revenue Growth: 1.48%
• EPS Growth: -174.61%
• Country: CA
• Employees: 2,440
• Sector: Healthcare
• Sector Strength: 42
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.49
• Shares Outstanding: 108,759,750
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 62,639
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.10
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.86
• Enterprise Value/Market Cap: 34.48
• Enterprise Value/Revenue: 0.34
• Enterprise Value/Gross Profit: 3.53
• Enterprise Value/Ebitda: 6.37
• 1Y Price Target: $0.40
• Price Target Upside: 147.69% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 40 Underperform
• Price Target: C$0.00 ▼(-100.00%Downside)

Ayr Wellness is facing significant financial and operational challenges. The most impactful factors include financial instability with negative profitability, bearish technical signals, and recent corporate events that indicate regulatory compliance issues and delayed financial disclosures. The lack of earnings call data does not alter the overall negative outlook.

Ayr Wellness Business Overview & Revenue Model

Company Description

Ayr Wellness Inc., a vertically-integrated cannabis multi-state operator, cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizers. It also provides administrative, consulting, and operations support services to licensed cannabis companies. As of November 1, 2022, Ayr Wellness Inc. operated 52 dispensaries. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.

How the Company Makes Money

Ayr Wellness generates revenue through multiple streams in the cannabis industry. Primarily, the company earns income from the sale of cannabis products through its owned and operated retail dispensaries, as well as wholesale distribution to third-party dispensaries. Ayr Wellness benefits from its vertically integrated model, which allows for control over the entire supply chain from cultivation to retail. This integration enables the company to optimize production costs and maintain high product quality, contributing to its profitability. Additionally, strategic acquisitions and partnerships within key markets have expanded Ayr's footprint, enhancing its revenue potential. The company also capitalizes on branding and marketing efforts to strengthen customer loyalty and drive sales growth.

Ayr Wellness Financial Statement Overview

Summary

Ayr Wellness is experiencing financial challenges, including declining profitability, increasing debt levels, and negative cash flows. Operational inefficiencies and leverage issues are significant concerns.

Income Statement

Ayr Wellness has faced declining profitability with negative EBIT and net income over the recent years. Revenue has been stagnant, and margins, including gross profit, have decreased. The company shows no revenue growth and negative EBIT and EBITDA margins, indicating operational inefficiencies.

Balance Sheet

The balance sheet shows a reasonable equity ratio, but the debt-to-equity ratio has been increasing, indicating rising leverage. The return on equity is negative due to ongoing losses, which suggests potential financial instability.

Cash Flow

Cash flow is a concern with negative free cash flow and declining operating cash flow. The operating cash flow to net income ratio is weak, and the company struggles to generate cash from its operations, raising liquidity risks.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	463.63M	463.63M	465.62M	357.61M	155.11M
Gross Profit	176.68M	202.44M	190.44M	138.10M	103.10M
EBITDA	-154.53M	84.60M	-67.66M	87.69M	17.21M
Net Income	-359.31M	-272.43M	-245.47M	-16.95M	-176.33M
Balance Sheet
Total Assets	1.27B	1.46B	1.76B	1.86B	615.87M
Cash, Cash Equivalents and Short-Term Investments	35.48M	50.77M	80.64M	154.34M	127.24M
Total Debt	621.88M	597.77M	621.66M	483.82M	190.62M
Total Liabilities	904.31M	889.20M	928.56M	839.85M	465.01M
Stockholders Equity	379.53M	581.78M	833.32M	1.02B	150.86M
Cash Flow
Free Cash Flow	-15.14M	-12.44M	-96.66M	-127.78M	21.74M
Operating Cash Flow	9.63M	27.16M	-34.16M	-27.78M	36.51M
Investing Cash Flow	-21.81M	-24.15M	-66.50M	-219.63M	-62.25M
Financing Cash Flow	-3.10M	-32.89M	26.96M	274.51M	144.57M

Ayr Wellness Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.16
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AYR.A, the sentiment is Negative. The current price of 0.16 is above the 20-day moving average (MA) of 0.15, below the 50-day MA of 0.26, and below the 200-day MA of 0.92, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 29.79 is Positive, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:AYR.A.

Ayr Wellness Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.41B	0.36	-61.88%	2.33%	16.99%	1.69%
AYR.A	40 Underperform	$18.10M	―	-74.75%	―	1.48%	-174.61%
OGI		$179.69M	19.85	4.76%	―	―	―
CBWTF		$91.34M	5.80	18.60%	―	―	―
MEDIF		$21.20M	―	-16.22%	―	―	―
PLNH		$59.33M	―	-39.53%	―	―	―
TSND	45 Neutral	C$129.50M	―	-38.89%	―	-6.80%	11.94%

Ayr Wellness Corporate Events

AYR Wellness Delays Q1 2025 Financial Filings Amid Debt Negotiations

AYR Wellness has announced a delay in filing its interim financial statements for Q1 2025 due to ongoing negotiations with creditors and the assessment of debt obligations. This delay has resulted in a failure-to-file cease-trade order from the Ontario Securities Commission, halting trading of AYR’s securities in Canada until the filings are completed and requirements are met.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

AYR Wellness Extends Waiver Agreement to Strengthen Financial Position

AYR Wellness has extended its Limited Waiver Agreement with senior noteholders, allowing more time to address financial obligations. This extension provides the company with additional flexibility to negotiate with lenders and explore strategic options to strengthen its capital structure, although it does not permanently resolve existing defaults.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

AYR Wellness Faces Filing Delays Amid Debt Negotiations

AYR Wellness Inc. has announced a delay in filing its interim financial statements for the first quarter of 2025 due to ongoing negotiations with creditors and the assessment of debt obligations. This delay has led to a failure-to-file cease-trade order from the Ontario Securities Commission, suspending trading of AYR’s securities in Canadian jurisdictions. Despite this, AYR does not anticipate any impact on its regular operations and is working to complete the filings promptly, with an update expected by June 27, 2025.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

AYR Wellness Secures Temporary Waiver to Address Financial Obligations

AYR Wellness Inc. has entered into a Limited Waiver Agreement with the majority of its senior secured noteholders, providing a temporary waiver for certain defaults related to delayed financial filings and payment obligations. This agreement grants AYR additional time to negotiate with senior lenders and explore strategic alternatives to address its capital structure, while maintaining its business operations and commitment to delivering quality cannabis products.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

AYR Wellness Faces Cease Trade Order Amid Filing Delays

AYR Wellness Inc. has announced an update regarding the status of its securities following a delay in filing its interim financial statements for the quarter ending March 31, 2025. As a result of the delay, the Ontario Securities Commission has issued a Failure to File Cease Trade Order, prohibiting trading of the company’s securities in Canada, with limited exceptions. AYR is actively working to resolve the issue and does not anticipate any disruption to its regular operations or its commitment to delivering quality cannabis products.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.75 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

AYR Wellness Delays Q1 2025 Financial Filings Amid Strategic Review

AYR Wellness Inc. announced a delay in filing its Q1 2025 financial statements and management discussion due to ongoing strategic review processes and negotiations with creditors. The Ontario Securities Commission will issue a cease-trade order, halting trading of AYR’s securities in Canada until the filings are completed, which is expected by June 13, 2025. Despite this, AYR does not anticipate any impact on its regular operations.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

AYR Wellness Announces Leadership Transition with New Interim CEO

AYR Wellness Inc. has announced a leadership change with Scott Davido appointed as the new Interim Chief Executive Officer, succeeding Steven M. Cohen. This transition is part of AYR’s strategic initiatives to enhance its operational and financial performance, with Davido bringing extensive experience in leading companies through periods of transition. The company aims to leverage this leadership change to further its growth and success in the cannabis industry.